Molecular Determinants Underlying the Anti-Cancer Efficacy of CD38 Monoclonal Antibodies in Hematological Malignancies
10.3390/biom12091261
Saved in:
Main Authors: | , , , |
---|---|
Other Authors: | |
Format: | Review |
Language: | English |
Published: |
MDPI
2022
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/234467 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
id |
sg-nus-scholar.10635-234467 |
---|---|
record_format |
dspace |
spelling |
sg-nus-scholar.10635-2344672024-04-18T01:03:45Z Molecular Determinants Underlying the Anti-Cancer Efficacy of CD38 Monoclonal Antibodies in Hematological Malignancies Mustafa, Nurulhuda Azaman, Muhamad Irfan Ng, Giselle GK Chng, Wee Joo CANCER SCIENCE INSTITUTE OF SINGAPORE MEDICINE Science & Technology Life Sciences & Biomedicine Biochemistry & Molecular Biology CD38 immunotherapy blood malignancies daratumumab drug combination extracellular vesicles miRNA CHRONIC LYMPHOCYTIC-LEUKEMIA MULTIPLE-MYELOMA CELLS T-CELL RETINOIC ACID OPEN-LABEL REGULATORY CELLS MUTATION STATUS FLOW-CYTOMETRY B-CLL EXPRESSION 10.3390/biom12091261 BIOMOLECULES 12 9 2022-11-14T03:34:28Z 2022-11-14T03:34:28Z 2022-09-01 2022-11-13T14:55:30Z Review Mustafa, Nurulhuda, Azaman, Muhamad Irfan, Ng, Giselle GK, Chng, Wee Joo (2022-09-01). Molecular Determinants Underlying the Anti-Cancer Efficacy of CD38 Monoclonal Antibodies in Hematological Malignancies. BIOMOLECULES 12 (9). ScholarBank@NUS Repository. https://doi.org/10.3390/biom12091261 2218-273X https://scholarbank.nus.edu.sg/handle/10635/234467 en MDPI Elements |
institution |
National University of Singapore |
building |
NUS Library |
continent |
Asia |
country |
Singapore Singapore |
content_provider |
NUS Library |
collection |
ScholarBank@NUS |
language |
English |
topic |
Science & Technology Life Sciences & Biomedicine Biochemistry & Molecular Biology CD38 immunotherapy blood malignancies daratumumab drug combination extracellular vesicles miRNA CHRONIC LYMPHOCYTIC-LEUKEMIA MULTIPLE-MYELOMA CELLS T-CELL RETINOIC ACID OPEN-LABEL REGULATORY CELLS MUTATION STATUS FLOW-CYTOMETRY B-CLL EXPRESSION |
spellingShingle |
Science & Technology Life Sciences & Biomedicine Biochemistry & Molecular Biology CD38 immunotherapy blood malignancies daratumumab drug combination extracellular vesicles miRNA CHRONIC LYMPHOCYTIC-LEUKEMIA MULTIPLE-MYELOMA CELLS T-CELL RETINOIC ACID OPEN-LABEL REGULATORY CELLS MUTATION STATUS FLOW-CYTOMETRY B-CLL EXPRESSION Mustafa, Nurulhuda Azaman, Muhamad Irfan Ng, Giselle GK Chng, Wee Joo Molecular Determinants Underlying the Anti-Cancer Efficacy of CD38 Monoclonal Antibodies in Hematological Malignancies |
description |
10.3390/biom12091261 |
author2 |
CANCER SCIENCE INSTITUTE OF SINGAPORE |
author_facet |
CANCER SCIENCE INSTITUTE OF SINGAPORE Mustafa, Nurulhuda Azaman, Muhamad Irfan Ng, Giselle GK Chng, Wee Joo |
format |
Review |
author |
Mustafa, Nurulhuda Azaman, Muhamad Irfan Ng, Giselle GK Chng, Wee Joo |
author_sort |
Mustafa, Nurulhuda |
title |
Molecular Determinants Underlying the Anti-Cancer Efficacy of CD38 Monoclonal Antibodies in Hematological Malignancies |
title_short |
Molecular Determinants Underlying the Anti-Cancer Efficacy of CD38 Monoclonal Antibodies in Hematological Malignancies |
title_full |
Molecular Determinants Underlying the Anti-Cancer Efficacy of CD38 Monoclonal Antibodies in Hematological Malignancies |
title_fullStr |
Molecular Determinants Underlying the Anti-Cancer Efficacy of CD38 Monoclonal Antibodies in Hematological Malignancies |
title_full_unstemmed |
Molecular Determinants Underlying the Anti-Cancer Efficacy of CD38 Monoclonal Antibodies in Hematological Malignancies |
title_sort |
molecular determinants underlying the anti-cancer efficacy of cd38 monoclonal antibodies in hematological malignancies |
publisher |
MDPI |
publishDate |
2022 |
url |
https://scholarbank.nus.edu.sg/handle/10635/234467 |
_version_ |
1800915702570287104 |